Amorepacific Corp. (090435.KS,090430.KS),a South Korean beauty and cosmetics company, Tuesday said that it had recently signed a Memorandum of Understanding or MoU with Viol Medical, a medical devices manufacturer, to work together in the beauty and medical sectors.
The company said that the partnership will focus on combining Amorepacific's skincare expertise with Viol Medical's device technology to develop new products and services, including home beauty devices. The two companies will also work together on product development and marketing, it added.
As part of strengthening this collaboration, Amorepacific said that it has made a strategic investment in Viol Medical.
Commenting on the developments, Sean Kim, CEO of Amorepacific, said, "Since its founding, Amorepacific has led Korea's beauty industry through long-standing research and expertise in skin science. Through our partnership with Viol Medical, we aim to connect professional treatment settings with everyday home care and offer new beauty solutions to customers worldwide."
On the Korean Stock Exchange, 090435.KS ended Monday's trading at 46,300.00 South Korean Won, down 1.2 percent.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.